Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy

被引：0

作者：

Roviello, F. ^{[1
]}

Caruso, S. ^{[1
]}

Marrelli, D. ^{[1
]}

Pedrazzani, C. ^{[1
]}

Neri, A. ^{[1
]}

De Stefano, A. ^{[1
]}

Pinto, E. ^{[1
]}

机构：

[1] Univ Siena, Policlin Le Scotte, Dipartimento Patol Umana & Oncol, Sez Chirurgia Oncol, Siena, Italy

来源：

GIORNALE DI CHIRURGIA | 2011年 / 32卷 / 04期

关键词：

Carcinosi peritoneale; Chirurgia citoriduttiva; Chemioterapia ipertermica intraperitoneale;

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

Peritoneal carcinomatosis (PC) had for long been regarded as a terminal disease, characterized by a very poor survival and worthy of being treated with palliative therapy only. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) provide a promising additional treatment option for patients with peritoneal carcinomatosis, resulting in recently published series enable to obtain long-term survival. In spite of the need for more high quality studies, there is now a consensus among many international experts about the use of this new strategy as gold standard for treating with intent of cure selected patients with PC. We summarized the present status and possible future progress of this treatment modality, in particular outlining its rationale, current practice and general outcomes.

引用

下载

页码：211 / 233

页数：23

共 50 条

[21] Treatment of peritoneal carcinomatosis with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: State of the art and future developments
Roviello, Franco
Caruso, Stefano
Marrelli, Daniele
Pedrazzani, Corrado
Neri, Alessandro
De Stefano, Alfonso
Pinto, Enrico
SURGICAL ONCOLOGY-OXFORD, 2011, 20 (01): : E38 - E54
[22] Treatment of peritoneal carcinomatosis from colorectal cancer by cytoreductive surgery and hyperthermic perioperative intraperitoneal chemotherapy
Kecmanovic, DM
Pavlov, MJ
Ceranic, MS
Sepetkovski, AV
Kovacevic, PA
Stamenkovic, AB
EJSO, 2005, 31 (02): : 147 - 152
[23] Cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis of colorectal origin
Cioppa, T.
Vaira, M.
Bing, C.
D'Amico, S.
Caponi, A.
Fiorentin, G.
De Simone, M.
GIORNALE DI CHIRURGIA, 2009, 30 (05): : 196 - 200
[24] Cost-effectiveness of Iterative Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis
COLBOURNE, J. A. M. E. S. R. M.
ALHAYO, S. A. M. T.
NANDAKUMAR, B. E. E. S. H. M. A. N.
BARAT, S. H. O. M. A.
LIAUWI, W. I. N. S. T. O. N.
MORRIS, D. A. V. I. D. L.
ALZAHRANI, N. A. Y. E. F. A.
IN VIVO, 2022, 36 (03): : 1527 - 1533
[25] CYTOREDUCTIVE SURGERY AND INTRAPERITONEAL CHEMOTHERAPY FOR PERITONEAL CARCINOMATOSIS
LYERLY, HK
ANNALS OF SURGERY, 1995, 221 (02) : 123 - 123
[26] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Sarcomatosis
Salti, George I.
Ailabouni, Luay
Undevia, Samir
ANNALS OF SURGICAL ONCOLOGY, 2012, 19 (05) : 1410 - 1415
[27] Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Sarcomatosis
George I. Salti
Luay Ailabouni
Samir Undevia
Annals of Surgical Oncology, 2012, 19 : 1410 - 1415
[28] Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Sarcomatosis
Yurttas, Can
Ladurner, Ruth
Mihaljevic, Andre L.
Strohaeker, Jens
CANCERS, 2024, 16 (17)
[29] PALLIATIVE CHEMOTHERAPY COMPARED WITH CYTOREDUCTIVE SURGERY AND HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY FOR PATIENTS WITH COLORECTAL PERITONEAL CARCINOMATOSIS
Chia, C. S.
Tan, G. H.
Soo, K. C.
Teo, M. C.
EUROPEAN JOURNAL OF CANCER, 2015, 51 : E11 - E11
[30] HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY IMPROVES SURVIVAL AFTER CYTOREDUCTIVE SURGERY FOR PERITONEAL CARCINOMATOSIS IN THE RAT
Klaver, Y. L. B.
Hendriks, T.
Lomme, R. M. L. M.
Rutten, H. J. T.
Bleichrodt, R. P.
De Hingh, I. H. J. T.
ANNALS OF ONCOLOGY, 2010, 21 : I55 - I56

← 1 2 3 4 5 →